A detailed history of Raymond James & Associates transactions in Organovo Holdings, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 19,622 shares of ONVO stock, worth $8,829. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,622
Previous 19,622 -0.0%
Holding current value
$8,829
Previous $14,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$0.75 - $1.35 $150 - $270
-200 Reduced 1.01%
19,622 $14,000
Q4 2023

Jan 16, 2024

BUY
$1.05 - $1.84 $20,813 - $36,472
19,822 New
19,822 $22,000
Q1 2021

May 14, 2021

SELL
$8.67 - $21.7 $99,531 - $249,116
-11,480 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$7.19 - $17.05 $82,541 - $195,734
11,480 New
11,480 $141,000

Others Institutions Holding ONVO

About ORGANOVO HOLDINGS, INC.


  • Ticker ONVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,712,020
  • Market Cap $3.92M
  • Description
  • Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparin...
More about ONVO
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.